![Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-013-0063-y/MediaObjects/12325_2013_63_Fig1_HTML.gif)
Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink
![Table 3 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar Table 3 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/84246e2eeb4dcef6ab85dcc893756c7060f16437/4-Table3-1.png)
Table 3 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar
Conversion from Epoetin Alfa to Darbepoetin Alfa: Effects on Patients' Hemoglobin and Costs to Canadian Dialysis Centres
![PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f91306ab176272ee910094f0aa47de05a6c26329/2-Figure1-1.png)
PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar
![PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f91306ab176272ee910094f0aa47de05a6c26329/3-Table1-1.png)
PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar
![Switch From Epoetin Beta to Darbepoetin Alfa Treatment of Anemia in Taiwanese Hemodialysis Patients: Dose Equivalence by Hemoglobin Stratification - Liao - 2016 - Therapeutic Apheresis and Dialysis - Wiley Online Library Switch From Epoetin Beta to Darbepoetin Alfa Treatment of Anemia in Taiwanese Hemodialysis Patients: Dose Equivalence by Hemoglobin Stratification - Liao - 2016 - Therapeutic Apheresis and Dialysis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/92d483be-36f4-491c-a28f-345d24eed5e8/tap12401-fig-0001-m.jpg)
Switch From Epoetin Beta to Darbepoetin Alfa Treatment of Anemia in Taiwanese Hemodialysis Patients: Dose Equivalence by Hemoglobin Stratification - Liao - 2016 - Therapeutic Apheresis and Dialysis - Wiley Online Library
![Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients | Renal Replacement Therapy | Full Text Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients | Renal Replacement Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41100-016-0037-z/MediaObjects/41100_2016_37_Fig1_HTML.gif)
Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients | Renal Replacement Therapy | Full Text
RESISTANCE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY - STUDIES IN EXPERIMENTAL MODELS OF ANEMIA AND CHRONIC KIDNEY DISEASE
Erythropoiesis-stimulating agents (epoetin alfa, beta, theta and zeta; and, darbepoetin alfa) for treating cancer- treatment ind
Conversion from Epoetin Alfa to Darbepoetin Alfa: Effects on Patients' Hemoglobin and Costs to Canadian Dialysis Centres
![Table 4 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar Table 4 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/84246e2eeb4dcef6ab85dcc893756c7060f16437/5-Table4-1.png)